Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-08-18FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for paroxetine submitted by Padagis US LLC. This action represents an additional regulatory appr…
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Venlafaxine Hydrochloride from Dr. Reddy's Laboratories Limited for a generic venlafaxine hydroc…
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Venlafaxine from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. under an ANDA.
-
FDA approval · 2023-08-17FDA Approved: HYDROXYZINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved an original application for hydroxyzine hydrochloride from Rising Pharma Holdings, Inc., confirming a generic antihistamine pro…
-
FDA approval · 2023-08-16FDA Approved: DOXEPIN — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for a generic doxepin product (DOXEPIN) from Zydus Lifesciences Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-08-09FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc., indicating an update to the produ…
-
FDA approval · 2023-07-21FDA Approved: PREGABALIN — Supplemental Application (Eskayef Pharmaceuticals Limited)
FDA approved a supplemental application for pregabalin (generic) submitted by Eskayef Pharmaceuticals Limited.
-
FDA approval · 2023-06-30FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Alprazolam from Sandoz Inc, indicating a regulatory approval related to a generic product.
-
FDA approval · 2023-06-27FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Micro Labs Limited)
FDA approved the original abbreviated new drug application for doxepin hydrochloride from Micro Labs Limited. Doxepin hydrochloride is used …
-
FDA approval · 2023-06-26FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' supplemental application for pregabalin under ANDA 207623, indicating approval of changes to this gene…
-
FDA approval · 2023-06-23FDA Approved: ALPRAZOLAM EXTENDED RELEASE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for an extended-release formulation of alprazolam, adding the extended-release dosage form under the…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: A Pilot fMRI Study of TMS in Late-Life Severe Worry [NA]
A completed pilot fMRI study evaluating transcranial magnetic stimulation for late-life generalized anxiety disorder; results posted in 2023…
-
FDA approval · 2023-06-21FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for pregabalin from Ascend Laboratories, LLC (ANDA207799), indicating approval of a supplemental fil…
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for a generic pregabalin from Rising Pharma Holdings, Inc., authorizing its marketing for the same i…
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for pregabalin from Alembic Pharmaceuticals Inc., enabling a generic version to be marketed.
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for pregabalin from Dr. Reddy's Laboratories Inc., authorizing a generic version under the approved …
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN CAPSULES, CV — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for Pregabalin Capsules, CV, enabling the marketing of a generic pregabalin capsule p…
-
FDA approval · 2023-06-07FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride by Macleods Pharmaceuticals Limited.
-
FDA approval · 2023-05-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved a generic version of venlafaxine hydrochloride from Granules Pharmaceuticals Inc. via an Original Application (ANDA), a generic…
-
FDA approval · 2023-05-02FDA Approved: DULOXETINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application from Actavis Pharma, Inc. for duloxetine under ANDA 090776, granting approval for a supplemental cha…
-
FDA approval · 2023-05-02FDA Approved: DULOXETINE — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved a supplemental application for duloxetine submitted by Solco Healthcare US, LLC (ANDA206653), authorizing a change related …
-
FDA approval · 2023-04-25FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for diazepam (generic) under ANDA 071583. This represents a supplemental approval for a gene…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: rTMS Pilot for Anxiety [NA]
A terminated pilot clinical trial evaluating repetitive transcranial magnetic stimulation (rTMS) for Generalized Anxiety Disorder with resul…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder [Phase 3]
Phase 3 clinical trial update evaluating the safety of GABITRIL in adults with generalized anxiety disorder has completed.
-
FDA approval · 2023-04-12FDA Approved: VENLAFAXINE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s original generic application for venlafaxine. The approval covers generic venlafaxine for the treatmen…